trending Market Intelligence /marketintelligence/en/news-insights/trending/1AVBR4f5RsFiOF0wr6N-Ug2 content esgSubNav
In This List

Arix Bioscience leads $30M financing for Atox Bio

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Arix Bioscience leads $30M financing for Atox Bio

Arix Bioscience plc led an oversubscribed $30 million series F financing round for Atox Bio.

Participants included new investors Adams Street Partners, Asahi Kasei Corp. and additional undisclosed investors, plus existing investors SR One, OrbiMed, Lundbeckfonden Ventures, Becker and Integra Holdings.

Arix Bioscience is investing $8 million for an equity stake in Atox Bio.

As part of the financing, Arix Bioscience's Jonathan Tobin will be appointed a director of Atox Bio.